Bloomberg BusinessWeek: When a Miracle Cure Is Left on the Shelf

Written By Peter Slavish
FOXG1's Nicole Johnson in Bloomberg BusinessWeek on Rare Disease Gene Therapy

Nicole Johnson and her daughter, Josie.

Photographer: Donna Alberico for Bloomberg Businessweek

Johnson’s FOXG1 Research Foundation became a “virtual biotech company,” funding a lab with about 20 researchers to study the disease.

Photographer: Donna Alberico for Bloomberg Businessweek

Peter Slavish
Previous

2024 Impact Report & 2025 Goals: FOXG1 Research Foundation

Next

Based on ‘hope and love,’ UB celebrates opening of FOXG1 Research Center